$32.39
+0.120 (+0.372%)
At Close: Jun 03, 2026
Compass and Anywhere Real Estate Begin a New Chapter as One Company Built for Real Estate Professionals
08:00am, Friday, 09'th Jan 2026
NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) announces the completion of its all-stock combination with Anywhere Real Estate Inc. Following the merger, the two companies are comin
Compass Pathways: Exciting Prospects For This Psychedelic Pioneer With Significant Risks
01:25pm, Thursday, 08'th Jan 2026
Compass Pathways plc experienced an >80% rally since my last 'Hold' rating. CMPS has benefited from positive phase 3 trial results and positive political developments since my last article. Recent app
Compass (COMP) Surges 9.3%: Is This an Indication of Further Gains?
11:40am, Thursday, 08'th Jan 2026
Compass (COMP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Compass, Inc. Announces Upsize and Pricing of $850,000,000 Convertible Senior Notes
06:15am, Thursday, 08'th Jan 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) (the "Company"), today announced the pricing of its offering of $850.0 million in aggregate principal amount of convertible senior no
Stock Market Today, Jan. 7: Compass Surges After Announcing $750 Million Convertible Notes Offering
06:14pm, Wednesday, 07'th Jan 2026
On Jan. 7, 2026, investors weighed a massive notes deal, raised guidance, and an approved merger reshaping this real estate platform.
Compass Diversified Announces Third Quarter and Year-to-Date 2025 Earnings and Conference Call Information
04:10pm, Wednesday, 07'th Jan 2026
WESTPORT, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, ann
Compass and Anywhere Stockholders Overwhelmingly Approve Merger
03:37pm, Wednesday, 07'th Jan 2026
NEW YORK and MADISON, N.J., Jan. 7, 2026 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass") and Anywhere Real Estate Inc. (NYSE: HOUS) ("Anywhere") announce that stockholders of each company vote
Compass and Anywhere Clear a Key Merger Hurdle
10:05am, Wednesday, 07'th Jan 2026
Two of the nation's largest real estate brokerages are one step closer to combining.
Compass, Inc. Announces Proposed Offering of $750,000,000 Convertible Senior Notes
07:05am, Wednesday, 07'th Jan 2026
NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) (the "Company") announces that it intends to offer (the "Offering"), subject to market and other conditions, $750.0 million in aggrega
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
06:30am, Wednesday, 07'th Jan 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announc
Compass Therapeutics Provides Corporate Update
08:00am, Tuesday, 06'th Jan 2026
The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody)
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced toda
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 05'th Jan 2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Diversified Declares Fourth Quarter 2025 Distributions on Series A, B and C Preferred Shares
04:10pm, Monday, 05'th Jan 2026
WESTPORT, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of D
Compass Therapeutics Announces Key Leadership Appointments
08:00am, Monday, 05'th Jan 2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Sign In
Buy CMPGY